Effect of smokeless tobacco products on human oral bacteria growth and viability
Abstract
No abstract availableKeywords
Funding Information
- Center for Tobacco Products, U.S. Food and Drug Administration (E0747201)
- Oak Ridge Institute for Science and Education
- U.S. Department of Energy
- U.S. Food and Drug Administration
This publication has 38 references indexed in Scilit:
- Microbiology and Management of Pediatric Liver Abscesses: Two Cases Caused byStreptococcus anginosusGroupCase Reports in Infectious Diseases, 2012
- Effects of Orange II and Sudan III azo dyes and their metabolites on Staphylococcus aureusJournal of Industrial Microbiology and Biotechnology, 2011
- Oral Abscess Caused by Campylobacter rectus : Case Report and Literature ReviewJournal of Clinical Microbiology, 2009
- Smokeless tobacco use and salivary cotinine concentrationAddictive Behaviors, 2007
- Association of Eubacterium nodatum and Treponema denticola with human periodontitis lesionsOral Microbiology and Immunology, 2006
- Oral microbial communities in sickness and in healthTrends in Microbiology, 2005
- Detection frequency of periodontitis‐associated bacteria by polymerase chain reaction in subgingival and supragingival plaque of periodontitis and healthy subjectsOral Microbiology and Immunology, 2004
- Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine contentNicotine & Tobacco Research, 2003
- Health effects associated with smokeless tobacco: a systematic reviewThorax, 2003
- Biochemistry, Biology, and Carcinogenicity of Tobacco-Specific N-NitrosaminesChemical Research in Toxicology, 1998